Hisse Senetlerindeki Sıralama
#32234
Medicure Inc. is a biopharmaceutical firm focused on developing, researching,... Medicure Inc. is a biopharmaceutical firm focused on developing, researching, and commercializing therapeutic solutions for cardiovascular conditions across Canada and the United States. Its product portfolio includes AGGRASTAT, an injectable glycoprotein GP IIb/IIIa receptor antagonist prescribed for acute coronary syndromes, such as unstable angina and non-Q-wave myocardial infarction. The company also provides ZYPITAMAG, a medication used to manage primary hyperlipidemia and mixed dyslipidemia. Additionally, Medicure offers the ReDS system, a non-invasive medical device designed to measure lung fluid levels, aiding in the management of congestive heart failure. Another key offering is Sodium Nitroprusside injection, utilized for rapidly lowering blood pressure during hypertensive crises in both adult and pediatric patients, inducing controlled hypotension for surgical bleeding reduction, and treating acute congestive heart failure. These products are made available through both retail pharmacy networks and online platforms. Established in 1997, Medicure Inc. is headquartered in Winnipeg, Canada.
Ticaret Medicure Inc. (MPH)
B piyasa değeri ile MPH fiyatı
Piyasa Değeri Medicure Inc.(MPH)
Piyasa Değeri: $10.65M
August 2026 itibarıyla Medicure Inc. şirketinin piyasa değeri $10.65M. Bu, verilerimize göre Medicure Inc. şirketini dünyanın en değerli 32234th. şirketi yapar. Piyasa değeri, halka açık bir şirketin tedavüldeki hisse senetlerinin toplam piyasa değeri olup, bir şirketin değerini ölçmek için yaygın olarak kullanılır.
Medicure Inc. piyasa değeri geçmişi (2012 - 2026)
En Popüler 5 stocks ile karşılaştırıldığında MPH
| MPH’in Fiyatı |
|
B Varlığı |
B’nin Piyasa Değeri |
Sonuçlar |
|
|
|
|
$5.460T
|
+51,284,054.00%
|
|
|
|
|
$4.489T
|
+42,167,207.18%
|
|
|
|
|
$4.141T
|
+38,893,062.38%
|
|
|
|
|
$3.569T
|
+33,517,216.58%
|
|
|
|
|
$2.798T
|
+26,280,282.63%
|
